Pharmacotherapeutic options for the management of human polyomaviruses.
about
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantationRepression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin.Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremiaThe role of polyomaviruses in human disease.Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences.
P2860
Pharmacotherapeutic options for the management of human polyomaviruses.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pharmacotherapeutic options for the management of human polyomaviruses.
@ast
Pharmacotherapeutic options for the management of human polyomaviruses.
@en
type
label
Pharmacotherapeutic options for the management of human polyomaviruses.
@ast
Pharmacotherapeutic options for the management of human polyomaviruses.
@en
prefLabel
Pharmacotherapeutic options for the management of human polyomaviruses.
@ast
Pharmacotherapeutic options for the management of human polyomaviruses.
@en
P2093
P356
P1476
Pharmacotherapeutic options for the management of human polyomaviruses.
@en
P2093
Jennifer Trofe
Julie Roskopf
Nasimul Ahsan
Robert J Stratta
P304
P356
10.1007/0-387-32957-9_17
P407
P577
2006-01-01T00:00:00Z